+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 9Years - 17Years
All Genders
ID04805437

Comparing 3D Designed Boston Brace to Standard Boston Brace for Treating Idiopathic Scoliosis in Children and Adolescents

Led by Karolinska Institutet · Updated on 2025-02-21

170

Participants Needed

2

Research Sites

500 weeks

Total Duration

AI-Summary

What this Trial Is About

Idiopathic scoliosis is a common spinal deformity in children and adolescents, affecting about 3% of this population. Approximately 10% of these children develop a curve severe enough to require treatment with a brace or surgery. Researchers are investigating whether a newly developed 3D designed Boston brace can improve comfort and wearing time compared to the standard Boston brace, as wearing time is crucial for treatment success. This study is a multicenter randomized controlled trial aiming to compare these two braces in skeletally immature patients with idiopathic scoliosis. Participants will be randomly assigned to wear either the standard Boston brace or the new 3D designed Boston brace. Both braces are designed to be worn for 20 hours or more per day until the patient reaches skeletal maturity. Patients are encouraged to maintain 60 minutes of physical activity daily. Compliance with wearing the brace will be monitored using a built-in thermal sensor. Follow-ups with clinical and radiological evaluations will occur every six months until skeletal maturity, then at 2, 5, and 10 years afterward. An observational group will include patients who choose not to be randomized but will receive the standard brace and similar follow-ups. During the study, participants will have in-brace radiographs after brace prescription and regular reassessments every six months. The research team will monitor curve progression, quality of life, and surgical rates as outcome measures. Wearing compliance will be tracked continuously by the thermal sensors. The study will continue until skeletal maturity, defined as less than 1 cm of height growth in six months, with long-term follow-up extending up to 10 years after maturity. A total of 85 participants per group are planned to ensure statistical power while considering possible dropouts.

CONDITIONS

Brief Title

Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression

Research Team

E

Elias Diarbakerli, PT, PhD

P

Paul Gerdhem, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here